From Surf Wiki (app.surf) — the open knowledge base
Diphtheria vaccine
Vaccine against diphtheria
Vaccine against diphtheria
| Field | Value |
|---|---|
| type | vaccine |
| image | DT-vaccine.jpg |
| caption | DT vaccine in Japan |
| target | *Corynebacterium diphtheriae* |
| vaccine_type | toxoid |
| MedlinePlus | a607027 |
| DailyMedID | |
| pregnancy_AU | |
| routes_of_administration | Intramuscular injection |
| ATC_prefix | J07 |
| ATC_suffix | AF01 |
| legal_AU | |
| legal_BR | |
| legal_CA | |
| legal_DE | |
| legal_NZ | |
| legal_UK | |
| legal_US | Rx-only |
| legal_US_comment | |
| legal_EU | Rx-only |
| legal_EU_comment | |
| legal_UN | |
| legal_status | |
| ChemSpiderID | none |
| Drugs.com =
Diphtheria vaccine is a toxoid vaccine against diphtheria, an illness caused by Corynebacterium diphtheriae. Its use has resulted in a more than 90% decrease in the number of cases globally between 1980 and 2000. The first dose is recommended at six weeks of age with two additional doses four weeks apart, after which it is about 95% effective during childhood. Three further doses are recommended during childhood. It is unclear if further doses later in life are needed.
The diphtheria vaccine is very safe. Significant side effects are rare. Pain may occur at the injection site. A bump may form at the site of injection that lasts a few weeks.
The diphtheria vaccine is delivered in several combinations. Some combinations (Td and DT vaccines) include tetanus vaccine, others (known as DPT vaccine or DTaP vaccine depending on the pertussis antigen used) comes with the tetanus and pertussis vaccines, and still others include additional vaccines such as Hib vaccine, hepatitis B vaccine, or inactivated polio vaccine. The World Health Organization (WHO) has recommended its use since 1974. About 84% of the world population is vaccinated. It is given as an intramuscular injection.
The diphtheria vaccine was developed in 1923. It is on the World Health Organization's List of Essential Medicines.
History

In 1890, Kitasato Shibasaburō and Emil von Behring at the University of Berlin reported the development of 'antitoxins' against diphtheria and tetanus. Their method involved injecting the respective toxins into animals and then purifying antibodies from their blood. Behring called this method 'serum therapy'. While effective against the pathogen, initial tests on humans were unsuccessful. By 1894, the production of antibodies had been optimised with help from Paul Ehrlich, and the treatment started to show success in humans. The serum therapy reduced mortality to 1–5%, although there were also reports of severe adverse reactions, including at least one death. Behring won the very first Nobel Prize in Physiology or Medicine for this discovery. Kitasato, however, was not awarded.
By 1913, Behring had created Antitoxin-Toxin (antibody-antigen) complexes to produce the diphtheria AT vaccine. In the 1920s, Gaston Ramon developed a cheaper version by using formaldehyde-inactivated toxins. As the use of these vaccines spread across the world, the number of diphtheria cases was greatly reduced. In the United States alone, the number of cases fell from 100,000 to 200,000 per year in the 1920s to 19,000 in 1945 and 14 in the period 1996–2018.
Effectiveness
About 95% of people vaccinated develop immunity, and vaccination against diphtheria has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000. About 86% of the world population was vaccinated as of 2016.
Side effects
Severe side effects from diphtheria toxoid are rare. Pain may occur at the injection site. A bump may form at the site of injection that lasts a few weeks. Side effects of DTaP vaccines are similar but less frequent. Tetanus toxoid containing vaccines (Td, DT, DTP and DTaP) may cause brachial neuritis at a rate of 0.5 to 1 case per 100,000 toxoid recipients.
Recommendations
The World Health Organization has recommended vaccination against diphtheria since 1974. The first dose is recommended at six weeks of age with two additional doses four weeks apart, after receiving these three doses about 95% of people are immune. Three further doses are recommended during childhood. Booster doses every ten years are no longer recommended if this vaccination scheme of 3 doses + 3 booster doses is followed. Injection of 3 doses + 1 booster dose, provides immunity for 25 years after the last dose. If only three initial doses are given, booster doses are needed to ensure continuing protection.
References
References
- (27 October 2023). "Infanrix".
- (21 July 2022). "Daptacel".
- (26 April 2023). "Pediarix Page Lead".
- (27 October 2023). "Kinrix".
- (21 July 2022). "Quadracel".
- (12 April 2023). "Vaxelis".
- (21 October 2022). "Pentacel".
- (15 November 2018). "Tdvax".
- (16 December 2022). "Tenivac".
- (11 May 2023). "Adacel".
- (27 October 2023). "Boostrix".
- (14 January 2021). "List of nationally authorised medicinal products - Active substance: diphtheria / tetanus vaccines (adsorbed), diphtheria vaccines (adsorbed)". [[European Medicines Agency]].
- (2022). "Netter's Infectious Diseases". Elsevier.
- (2024). "Epidemiology and prevention of vaccine-preventable diseases". U.S. [[Centers for Disease Control and Prevention]] (CDC).
- "Diphtheria Vaccination". U.S. [[Centers for Disease Control and Prevention]] (CDC).
- (12 May 2025). "Diphtheria Vaccination". U.S. [[Centers for Disease Control and Prevention]] (CDC).
- (August 2017). "Diphtheria vaccine: WHO position paper – August 2017". Weekly Epidemiological Record.
- (2017). "Diphtheria vaccine: WHO position paper – August 2017". Weekly Epidemiological Record.
- (3 September 2014). "Diphtheria".
- (15 July 2025). "Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated – WHO, UNICEF".
- (2012). "Introduction to Epidemiology: Distribution and Determinants of Disease". Nelson Education.
- (2025). "The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list". World Health Organization.
- (10 May 2010). "A Diphtheria Cure, 1894".
- (February 2017). "Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes". mBio.
- (19 October 2022). "Diphtheria".
- (15 April 2019). "Tetanus".
- (10 October 2017). "Immunisatio".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Diphtheria vaccine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report